<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Arial",sans-serif;
color:#323232;
font-weight:normal;
font-style:normal;
text-decoration:none none;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<style type="text/css">.style1 {font-family: "Times New Roman";}</style></head><body lang="EN-GB" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-family:"Arial",sans-serif;color:#323232">There’s a post-print of the paywalled article available via… erm… ResearchGate…<br>
<br>
<a href="https://www.researchgate.net/publication/313606361_Copyright_compliance_and_infringement_in_ResearchGate_full-text_journal_articles">https://www.researchgate.net/publication/313606361_Copyright_compliance_and_infringement_in_ResearchGate_full-text_journal_articles</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Arial",sans-serif;color:#323232"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Arial",sans-serif;color:#323232">Tom.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Arial",sans-serif;color:#323232"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US" style="mso-fareast-language:EN-GB">From:</span></b><span lang="EN-US" style="mso-fareast-language:EN-GB"> goal-bounces@eprints.org [mailto:goal-bounces@eprints.org]
<b>On Behalf Of </b>Richard Poynder<br>
<b>Sent:</b> 01 March 2017 15:47<br>
<b>To:</b> goal@eprints.org<br>
<b>Subject:</b> [GOAL] ResearchGate announces $52m investment<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">It has been reported this week that in November 2015 ResearchGate received $52m in investment money, although the investment has only just been made public.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">News items below. <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="https://www.researchinformation.info/news/researchgate-announces-52m-investment">https://www.researchinformation.info/news/researchgate-announces-52m-investment</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="http://uk.businessinsider.com/researchgate-raised-52-million-goldman-bill-gates-2017-2?r=US&IR=T">http://uk.businessinsider.com/researchgate-raised-52-million-goldman-bill-gates-2017-2?r=US&IR=T</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="https://www.nytimes.com/2017/02/28/technology/science-research-researchgate-gates-goldman.html?smid=tw-share&_r=2">https://www.nytimes.com/2017/02/28/technology/science-research-researchgate-gates-goldman.html?smid=tw-share&_r=2</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Of note: this paywalled article reports that 51% of a random sample of non-OA articles on ResearchGate infringed the copyright and were non-compliant with publishers’ policy.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="https://link.springer.com/article/10.1007/s11192-017-2291-4">https://link.springer.com/article/10.1007/s11192-017-2291-4</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Amongst those to invest in the company were the Wellcome Trust. It would be interesting to hear more from Wellcome as to why it has invested in ResearchGate.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Richard Poynder<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<br /><br /><p style="font-family: Verdana; font-size:10pt; color:#666666;"><b>Disclaimer</b></p><p style="font-family: Verdana; font-size:8pt; color:#666666;">The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.<br /><br /></p></body></html>